Neuraxis, Inc. (NRXS) Earnings Call Analysis
AMEX · Healthcare · Biotechnology
Earnings Reports
-
Neuraxis (NRXS) Q1 2026: 33% ASP Lift Signals Reimbursement-Driven Margin Expansion
May 12, 2026
-
NeurAxis (NRXS) Q4 2025: Prior Auth Submissions Surge 10x as CPT Code Unlocks Pediatric Pipeline
March 19, 2026
-
NeurAxis (NRXS) Q3 2025: 22% Revenue Growth Sets Stage for CPT Code-Driven Inflection
November 11, 2025
-
NeurAxis (NRXS) Q2 2025: 46% Revenue Growth Sets Stage for CPT Code-Driven Inflection
August 12, 2025